We are live on ! Find out more
DS

DRW Securities Portfolio holdings

AUM $4.11B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
-10.41%
1 Year Est. Return
+21.98%
3 Year Est. Return
+96.16%
5 Year Est. Return
+100.81%
10 Year Est. Return
+306.64%
AUM
$903M
AUM Growth
-$17.9M
Cap. Flow
-$7.67M
Cap. Flow %
-0.85%
Top 10 Hldgs %
93.34%
Holding
139
New
30
Increased
24
Reduced
13
Closed
62

Sector Composition

Rank Sector Weight
1 Miscellaneous 96.17%
2 Financials 1.46%
3 Healthcare 1.33%
4 Industrials 0.34%
5 Technology 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPI
126
DELISTED
NUVEEN PREMIUN INC MUN FUND
NPI
-19,900
Closed -$261K
SQNM
127
DELISTED
SEQUENOM INC NEW
SQNM
-116,900
Closed -$355K
SQNM
128
PUT
DELISTED
SEQUENOM INC NEW
SQNM
-116,900
Closed -$355K
NIO
129
DELISTED
NUVEEN MUNICIPAL OPPORTUNITY FUND INC
NIO
-13,218
Closed -$180K
ATML
130
CALL
DELISTED
ATMEL CORP
ATML
-67,800
Closed -$668K
MSO
131
CALL
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
-103,700
Closed -$647K
RYL
132
CALL
DELISTED
RYLAND GROUP INC
RYL
-19,500
Closed -$904K
CMCSK
133
CALL
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
-79,800
Closed -$4.78M
CTIC
134
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-25,000
Closed -$488K
BDSI
135
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-65,000
Closed -$517K
OREX
136
DELISTED
Orexigen Therapeutics, Inc.
OREX
-6,610
Closed -$327K
NMRX
137
DELISTED
Numerex Corp
NMRX
-42,000
Closed -$359K
MDVN
138
DELISTED
MEDIVATION, INC.
MDVN
-16,000
Closed -$914K
ARMH
139
DELISTED
ARM HOLDINGS PLC ADS
ARMH
-11,100
Closed -$547K

Similar funds

DRW Securities's Q3 2015 Portfolio in Review

As of Q3 2015, DRW Securities held 139 positions worth $903M, down 1.9% from $921M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

DRW Securities's Q3 2015 filing shows 30 new, 24 increased, 13 reduced and 62 closed positions. Its largest new stake was Gilead Sciences: 51,000 shares worth $5.01M. The largest sale was Vertex Pharmaceuticals, an estimated $10.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 94% a quarter earlier, followed by Financials and Healthcare.

  • DRW Securities's largest Q3 2015 buy was Gilead Sciences: 51,000 shares worth $5.01M.
  • DRW Securities added most to VelocityShares Daily Inverse VIX Short Term ETN in Q3 2015, an estimated $27.4M increase.
  • DRW Securities's biggest Q3 2015 reduction was Vanguard Total Bond Market, cutting an estimated $8.62M.
  • DRW Securities fully exited Vertex Pharmaceuticals in Q3 2015, selling an estimated $10.2M.
  • DRW Securities's ten largest holdings make up 93% of its $903M portfolio in Q3 2015.
  • DRW Securities opened 30 new positions and closed 62 in Q3 2015.
  • DRW Securities's portfolio value fell 1.9% quarter-over-quarter to $903M.

Based on DRW Securities's 13F filing for Q3 2015, filed 16 Nov 2015.